Additional file 1 of Multi-omics analysis reveals prognostic value of tumor mutation burden in hepatocellular carcinoma

Additional file 1. Supplementary Table S1: Clinical Characteristics of the HCC patients in TCGA and ICGC.Supplementary Table S2: TMB value of 365 HCC patients. Supplementary Table S3: The genes and corresponding modules after WGCNA. Supplementary Table S4: differentially expressed genes (DEGs) between low- and high-TMB groups. Supplementary Table S5: The Functional Annotation analysis of hub genes. Supplementary Table S6: The results of correlation of risk score with immune infiltrating cell.

补充材料1。补充表S1：癌症基因组图谱（The Cancer Genome Atlas, TCGA）与国际癌症基因组联盟（International Cancer Genome Consortium, ICGC）队列中肝细胞癌（Hepatocellular carcinoma, HCC）患者的临床特征。补充表S2：365例肝细胞癌患者的肿瘤突变负荷（Tumor Mutation Burden, TMB）值。补充表S3：加权基因共表达网络分析（Weighted Gene Co-expression Network Analysis, WGCNA）得到的基因及其对应模块。补充表S4：低TMB组与高TMB组间的差异表达基因（Differentially Expressed Genes, DEGs）。补充表S5：核心基因的功能注释分析结果。补充表S6：风险评分与免疫浸润细胞的相关性分析结果。